On Thursday, Analog Devices, Inc. (NASDAQ:ADI)’s shares declined -0.37% to $66.59.
Analog Devices, Inc. (ADI) a global leader in high-performance semiconductors for signal processing applications declared that Bruce R. Evans has been elected as a Director of the Company.
Mr. Evans is presently a Managing Director at Summit Partners, a growth equity, venture capital and alternative investment firm with considerable experience in technology, healthcare and other growth verticals. He joined Summit in 1986 and has served as a director of over thirty companies, counting twelve public companies, during his time there. Mr. Evans presently also serves as the Chairman of Summit Partners’ Board of Managers.
In addition to his work accomplishments, Mr. Evans is a member of the Vanderbilt University Board of Trust and the Chairman of Vanderbilt’s Investment Committee.
Mr. Evans earned a BE in mechanical engineering and economics from Vanderbilt University and an MBA from Harvard Business School.
Analog Devices, Inc. engages in the design, manufacture, and marketing of analog, mixed-signal, and digital signal processing integrated circuits (ICs) for use in industrial, automotive, consumer, and communication markets worldwide. It offers signal processing products that convert, condition, and process real-world phenomena, such as temperature, pressure, sound, light, speed, and motion into electrical signals. The company’s products comprise data converters, which translate real-world analog signals into digital data and translate digital data into analog signals; high-performance amplifiers to condition analog signals; and radio frequency ICs to support cellular infrastructure.
Liberty Global plc - Class C Ordinary Shares (NASDAQ:LBTYK)’s shares dropped -0.09% to $52.92.
Liberty Global plc - Class C Ordinary Shares (LBTYK) declared that, following regulatory approval, it has consummated its formerly declared acquisition of 100% of the parent of Puerto Rico Cable Acquisition Company Inc., dba Choice Cable TV (“Choice”), the second largest cable and broadband services provider in Puerto Rico. The combination of Choice’s operations with those of Liberty Cablevision of Puerto Rico LLC (“LCPR”), which is 60% owned by Liberty Global and 40% owned by funds managed by Searchlight Capital Partners, L.P., creates the largest cable operator on the island with over one million homes passed1, serving about 750,000 revenue generating units (“RGUs)1 and generating over $390 million of annual revenue.
As formerly revealed, the purchase price of about $272.5 million before transaction costs and other adjustments represents a multiple of about 6 times our estimate of Choice’s 2015 full-year operating cash flow, as customarily defined by Liberty Global and adjusted for the projected annual impact of synergies following full integration. The transaction was largely funded through incremental debt borrowings of about $267.5 million at the combined Puerto Rican business, and equity contributions from Liberty Global and Searchlight of $10.2 million and $6.8 million, respectively.
Liberty Global plc, together with its auxiliaries, provides video, broadband Internet, fixed-line telephony, and mobile services in Europe, Chile, Puerto Rico, and internationally. The company offers various residential services, counting video services comprising basic and premium programming, which can be viewed on the television and Internet connected devices; electronic programming guide, high definition (HD) channels, digital video recorder (DVR), and HD DVR services; video-on-demand, set-top boxes, pay-per-view programming, and programming in three-dimensional format services, in addition to television applications that allow access to programming on laptops, smartphones, and tablets; and entertainment, sports, movies, documentaries, lifestyles, news, adult, children, and ethnic and foreign channels.
At the end of Thursday’s trade, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)‘s shares showed no change to $8.69.
Ariad Pharmaceuticals, Inc. (ARIA) declared long-term follow up from its pivotal Phase 2 trial of Iclusig® (ponatinib), its approved BCR-ABL inhibitor, in heavily pretreated patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The study now shows that with a median follow-up of about 3.5 years for chronic phase CML (CP-CML) patients and a median follow-up of about 2.9 years in all patients in the trial, Iclusig continues to demonstrate anti-leukemic activity in patients with limited treatment options. Responses have been maintained long-term in CP-CML patients. Eighty-three percent (83%) of CP-CML patients who achieved a major cytogenetic response (MCyR) are estimated to remain in MCyR at three years.
Additionally, 95 percent of CP-CML patients who underwent ponatinib dose reductions maintained their responses (MCyR). Benefit-risk evaluations should guide the decision to initiate and maintain Iclusig therapy, particularly in patients who may be at raised risk for arterial occlusive events (AOE).
ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult patients with chronic myeloid leukemia (CML), and Philadelphia chromosome-positive acute lymphoblastic leukemia in the United States, Europe, and other territories. It also develops Brigatinib, an investigational inhibitor of anaplastic lymphoma kinase for the treatment of various patients with a form of non-small cell lung cancer; and AP32788, an orally active TKI for treating non-small cell lung cancer and various other solid tumors.
Check Point Software Technologies Ltd. (NASDAQ:CHKP), ended its Thursday’s trading session with -0.99% loss, and closed at $80.73.
Check Point Software Technologies Ltd. (CHKP) the largest pure-play security vendor globally, recently declared the results of its 2015 Annual General Meeting. The company presented six proposals for the shareholders vote at the meeting, counting reappointment of the company’s directors and auditors, and the seventh proposal was withdrawn. About 142 million shares, representing about 78% of the shares outstanding as of the record date, were voted at the meeting.
All proposals voted on at the Annual General Meeting were adopted by an overwhelming majority vote of the shareholders.
Check Point would like to thank shareholders for the support and confidence they have in the company and its employees and for their vote at the Annual General Meeting.
Check Point Software Technologies Ltd. develops, markets, and supports a range of software, combined hardware, and software products and services for information technology (IT) security worldwide. It offers a portfolio of network security, endpoint security, data security, and administration solutions.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
